Protein tyrosine phosphatase 1B (PTP1B), as a therapeutic target for the treatment of Type-II diabetes and obesity, has been the subject of intense study over the past decade [1,2,3,4,5]. The gene discussed is PTPN1; the disease is obesity due to melanocortin 4 receptor deficiency.